CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $26,552,861
- in 2 filings, $26.6M under 10b5-1 plans
Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-09-10 | Waddill William D. Director | Sale 10b5-1 | −8,000 | $45.00 | $360K | 12,000 |
| 2024-09-10 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 0 | ||
| 2024-07-24 | Waddill William D. Director | Option exercise 10b5-1 | +8,000 | $12.88 | $103K | 20,000 |
| 2024-07-24 | Waddill William D. Director | Sale 10b5-1 | −8,000 | $40.00 | $320K | 12,000 |
| 2024-07-24 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 8,000 | ||
| 2024-06-13 | PATEL DINESH V PH D President and CEO | Gift | −1,000 | 514,415 | ||
| 2024-06-07 | Waddill William D. Director | Option exercise 10b5-1 | +8,000 | $12.88 | $103K | 20,000 |
| 2024-06-07 | Waddill William D. Director | Sale 10b5-1 | −8,000 | $35.00 | $280K | 12,000 |
| 2024-06-07 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 16,000 | ||
| 2024-06-07 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −35,000 | $35.19 | $1.2M | 515,415 |
| 2024-04-18 | Ali Asif Chief Financial Officer | Sale | −1,234 | $25.11 | $31K | 37,163 |
| 2024-04-01 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −25,000 | $28.31 | $708K | 549,590 |
| 2024-03-07 | SELICK HAROLD E Director | Option exercise | +6,490 | $1.89 | $12K | 27,996 |
| 2024-03-07 | SELICK HAROLD E Director | Option exercise · Stock Option (right to buy) | −6,490 | 0 | ||
| 2024-03-01 | PATEL DINESH V PH D President and CEO | Sale 10b5-1 | −30,000 | $31.62 | $949K | 574,590 |
| 2024-03-01 | Waddill William D. Director | Option exercise 10b5-1 | +12,975 | $6.09 | $79K | 24,975 |
| 2024-03-01 | Waddill William D. Director | Sale 10b5-1 | −12,975 | $31.34 | $407K | 12,000 |
| 2024-03-01 | Waddill William D. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −12,975 | 0 | ||
| 2024-03-01 | Ali Asif Chief Financial Officer | Option exercise | +12,000 | $12.17 | $146K | 52,645 |
| 2024-03-01 | Ali Asif Chief Financial Officer | Sale | −12,000 | $32.22 | $387K | 40,645 |
Page 12 of 29 · 580 trades